| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/18/2002 | WO2002055693A2 Method for inhibiting the expression of a target gene |
| 07/18/2002 | WO2002055692A2 Method for inhibiting the expression of a target gene and medicament for treating a tumor disease |
| 07/18/2002 | WO2002055691A1 Gene encoding aip-1/flash promoter and use thereof |
| 07/18/2002 | WO2002055689A1 Rice sucrose transporter gene promoter |
| 07/18/2002 | WO2002055688A2 Histone deacetylase inhibitors in diagnosis and treatment of thyroid neoplasms |
| 07/18/2002 | WO2002055687A2 Transgenic mice containing target gene disruptions |
| 07/18/2002 | WO2002055685A2 Novel human kinase and polynucleotides encoding the same |
| 07/18/2002 | WO2002055684A2 Synthetic proteins containing a protein transduction domain |
| 07/18/2002 | WO2002055683A2 Galactosyltransferase homolog, znssp11 |
| 07/18/2002 | WO2002055681A2 Regulation of human tau-tubulin kinase |
| 07/18/2002 | WO2002055679A2 Thermostable lipolytic enzyme variant |
| 07/18/2002 | WO2002055677A1 Transplantation cell kits for re-myelination in nerve cells |
| 07/18/2002 | WO2002055674A1 Activation of nuclear transfer embryos |
| 07/18/2002 | WO2002055671A1 Bacillus subtilis var. chungkookjang producing high molecular weight poly-gamma-glutamic acid |
| 07/18/2002 | WO2002055668A2 Nucleotide sequences encoding variable regions of heavy and light chains of monoclonal antibody 1f7 |
| 07/18/2002 | WO2002055666A2 Method for identifying genes involved in cell proliferation |
| 07/18/2002 | WO2002055665A2 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders |
| 07/18/2002 | WO2002055664A2 Modulating insulin receptor signaling |
| 07/18/2002 | WO2002055663A2 Srebp pathway modulation through targeting hisrs |
| 07/18/2002 | WO2002055660A2 A positive selection vector system for direct pcr cloning |
| 07/18/2002 | WO2002055659A2 Antisense modulation of integrin beta 4 binding protein expression |
| 07/18/2002 | WO2002055658A2 Identification and characterization of an anthocyanin mutant (ant1) in tomato |
| 07/18/2002 | WO2002055651A2 Processes and vectors for plastid transformation |
| 07/18/2002 | WO2002055561A1 Method for surface display of proteins on genetic carriers |
| 07/18/2002 | WO2002055560A2 Monoclonal antibodies specific for the e2 glycoprotein of hepatitis c virus and their use in the diagnosis, treatment, and prevention of hepatitis c |
| 07/18/2002 | WO2002055557A2 Human proteins and nucleic acids encoding same |
| 07/18/2002 | WO2002055556A2 Regulation of human voltage gated potassium channel protein kv2.2 |
| 07/18/2002 | WO2002055555A2 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 07/18/2002 | WO2002055551A1 A novel polypeptide, a human cd63 antigen 56.87 and the polynucleotide encoding the polypeptide |
| 07/18/2002 | WO2002055549A2 Systems for expression of heterologous proteins in m. capsulatus |
| 07/18/2002 | WO2002055548A2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 07/18/2002 | WO2002055547A2 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 07/18/2002 | WO2002055535A2 Antisense modulation of cytohesin-1 expression |
| 07/18/2002 | WO2002055533A2 Methods of using imxp-888 and imxp-888 antagonists |
| 07/18/2002 | WO2002055532A2 Variant growth hormone molecules conjugated with macromolecular compounds |
| 07/18/2002 | WO2002055108A1 Targeted modification of intracellular compounds |
| 07/18/2002 | WO2002055104A2 Acne vaccine |
| 07/18/2002 | WO2002055098A2 Latency associated peptide for providing latency to pharmaceutically active proteins |
| 07/18/2002 | WO2002055010A2 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 07/18/2002 | WO2002054938A2 Treatment of disease by inducing cell apoptosis |
| 07/18/2002 | WO2002054885A1 Germinated seeds or sprouts in aquafeed compositions |
| 07/18/2002 | WO2002054865A1 Method of selecting antimicrobial agent and method of using the same |
| 07/18/2002 | WO2002054862A2 TRANSGENIC MICE CONTAINING Kv8.1 POTASSIUM CHANNEL ALPHA SUBUNIT GENE DISRUPTIONS |
| 07/18/2002 | WO2002054856A1 Chemical inhibitors of mismatch repair |
| 07/18/2002 | WO2002054851A2 Inhibition of pathological angiogenesis in vivo |
| 07/18/2002 | WO2002044382A8 Cytokine-like proteins |
| 07/18/2002 | WO2002044198A3 Haplotypes of the slc1a4 gene |
| 07/18/2002 | WO2002034280A3 Use of vanilloid 4 receptor and antagonists or agonists thereof for treating diseases associated with pain |
| 07/18/2002 | WO2002031025A3 Biodegradable poly(beta-amino esters) and uses thereof |
| 07/18/2002 | WO2002030945A3 Concatenated nucleic acid sequences |
| 07/18/2002 | WO2002029088A3 Highly expressible genes |
| 07/18/2002 | WO2002029003A3 Massive parallel method for decoding dna and rna |
| 07/18/2002 | WO2002028414B1 Compositions and methods for wt1 specific immunotherapy |
| 07/18/2002 | WO2002028351A3 Recombinant mucin binding proteins from steptococcus pneumoniae |
| 07/18/2002 | WO2002028164A3 Cloning endangered and extinct species |
| 07/18/2002 | WO2002027322A3 Reagents, method and kit for detecting phosphinothricin-n-acetyltransferase protein |
| 07/18/2002 | WO2002022776A3 Human coagulation factor vii variants |
| 07/18/2002 | WO2002021098B1 A method for identifying polymorphisms |
| 07/18/2002 | WO2002020597A3 Human vomeronasal receptor-5 |
| 07/18/2002 | WO2002018561A3 Modified fungal xylanases |
| 07/18/2002 | WO2002016549A3 METHODS OF TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES WITH CpG-CONTAINING POLYNUCLEOTIDE |
| 07/18/2002 | WO2002014482A3 Polyketides and their synthesis |
| 07/18/2002 | WO2002014472A3 Improved methods of gene silencing using inverted repeat sequences |
| 07/18/2002 | WO2002013758A3 System for regulating in vivo the expression of a transgene by conditional inhibition |
| 07/18/2002 | WO2002010411A3 Preparation of a recombinant protein in a prokaryotic host cell by improved codon use |
| 07/18/2002 | WO2002008437A3 Process for the fermentative preparation of l-glutamic acid using coryneform bacteria |
| 07/18/2002 | WO2002006834A9 Nested sorting and high throughput screening |
| 07/18/2002 | WO2002006316A3 Alpha-msh related compounds and methods of use |
| 07/18/2002 | WO2002006311A3 Olfactory g-protein coupled receptor |
| 07/18/2002 | WO2002004620A3 Method for isolating nucleic acids |
| 07/18/2002 | WO2002004522A3 Bifunctional molecules and vectors complexed therewith for targeted gene delivery |
| 07/18/2002 | WO2002004488A3 Nucleic acid binding polypeptides |
| 07/18/2002 | WO2002004020A3 Pathogen resistance in organisms |
| 07/18/2002 | WO2002002789A3 Compositions and methods for producing recombinant virions |
| 07/18/2002 | WO2002002633A3 Transporters and ion channels |
| 07/18/2002 | WO2002002143A3 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 07/18/2002 | WO2002000927A3 Diagnosis of diseases associated with development by means of assessing their methylation status |
| 07/18/2002 | WO2002000926A8 Diagnosis of diseases associated with signal transduction |
| 07/18/2002 | WO2002000169A3 Production of vaccines using transgenic plants |
| 07/18/2002 | WO2001094951A3 Inhibitors of c-reactive protein induced inflammation |
| 07/18/2002 | WO2001094607A3 High level production of p-hydroxybenzoic acid in green plants |
| 07/18/2002 | WO2001094551A3 Genetically modified t-cells, method for producing them and use thereof |
| 07/18/2002 | WO2001094391A3 Intracellular signaling proteins |
| 07/18/2002 | WO2001092504A8 Triacylglycerol lipases from arabidopsis thaliana |
| 07/18/2002 | WO2001090370A3 Method for microbial production of difructose anhydride iii, micro-organism used therefor and enzyme with inulase ii activity and dna sequences coding therefor |
| 07/18/2002 | WO2001090328A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/18/2002 | WO2001090323A3 46638, a putative family member of human lipoxygenase |
| 07/18/2002 | WO2001088163A9 Method for producing recombinant expansins |
| 07/18/2002 | WO2001088137A3 Human myd88 adapter-like protein and functional fragments thereof |
| 07/18/2002 | WO2001088134A3 Novel human lipocalin homologs and polynucleotides encoding the same |
| 07/18/2002 | WO2001088132A3 Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods |
| 07/18/2002 | WO2001087980A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 07/18/2002 | WO2001087936A3 Isolation of micromonospora carbonacea var africana pmlp1 integrase and use of integrating function for site-specific integration into micromonospora halophitica and micromonospora carbonacea chromosome |
| 07/18/2002 | WO2001085798A3 Human monoclonal antibodies to dendritic cells |
| 07/18/2002 | WO2001085790A3 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 07/18/2002 | WO2001085788A3 Human ion channels |
| 07/18/2002 | WO2001085783A3 Nucleic acids encoding polypeptides related to the alpha subunit of the glycoprotein hormone family and methods of use thereof |
| 07/18/2002 | WO2001084565A3 Method and apparatus for manufacture of magnetizable microparticles |
| 07/18/2002 | WO2001084149A3 Diagnostics and therapeutics for macular degeneration-related disorders |
| 07/18/2002 | WO2001083792A3 Enhanced gene expression in plants using transcription factors |